Kouji Yamamoto
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Kouji Yamamoto has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Sadao Tomizawa
Department of Information Science, Meisei University, Hino City, Japan
2 shared publications - Akiyo Yamasaki
Department of Metabolism, Endocrinology, and Molecular Medicine, Osaka City University Graduate School of Medicine, 1-4-3, Asahi-machi, Abeno-ku, Osaka, 545-8585, Japan
1 shared publication - Ayumi Shintani
Department of Medical Statistics, Osaka City University Graduate School of Medicine, Osaka 545-8586, Japan
1 shared publication - Daijiro Kabata
Center for Mathematical and Data Science, Kobe University, Kobe, Japan
1 shared publication - Haruo Shintaku
Department of Pediatrics, Osaka City University Graduate School of Medicine, Osaka 545-8585, Japan
1 shared publication - Kanae Takahashi
Hyogo Medical University
1 shared publication
Latest Publications
- Open Access
- 6 October 2022
- Published by MDPI AG in Mathematics
- Vol. 10 (19) , 3656
Joint Models for Incomplete Longitudinal Data and Time-to-Event Data
Clinical studies often collect longitudinal and time-to-event data for each subject. Joint modeling is a powerful methodology for evaluating the association between these data. The existing models, however, have not sufficiently addressed the problem of missing data, which are commonly encountered in longitudinal studies. In this paper, we introduce a novel joint model with shared random effects for incomplete longitudinal data and time-to-event data. Our proposed joint model consists of three submodels: a linear mixed model for the longitudinal data, a Cox proportional hazard model for the time-to-event data, and a Cox proportional hazard model for the time-to-dropout from the study. By simultaneously estimating the parameters included in these submodels, the biases of estimators are expected to decrease under two missing scenarios. We estimated the proposed model by Bayesian approach, and the performance of our method was evaluated through Monte Carlo simulation studies.
- 6 October 2022
- Published by MDPI AG in Mathematics
- Vol. 10 (19) , 3656
Open AccessJoint Models for Incomplete Longitudinal Data and Time-to-Event Data
Clinical studies often collect longitudinal and time-to-event data for each subject. Joint modeling is a powerful methodology for evaluating the association between these data. The existing models, however, have not sufficiently addressed the problem of missing data, which are commonly encountered in longitudinal studies. In this paper, we introduce a novel joint model with shared random effects for incomplete longitudinal data and time-to-event data. Our proposed joint model consists of three submodels: a linear mixed model for the longitudinal data, a Cox proportional hazard model for the time-to-event data, and a Cox proportional hazard model for the time-to-dropout from the study. By simultaneously estimating the parameters included in these submodels, the biases of estimators are expected to decrease under two missing scenarios. We estimated the proposed model by Bayesian approach, and the performance of our method was evaluated through Monte Carlo simulation studies.
- Open Access
Partial Asymmetry Measures for Square Contingency Tables
In square contingency table analysis, we consider a partial measure that represents the degree of departure from symmetry for each of several pairs. It may be useful to pool the values of the measure into a single summary measure of partial asymmetry. We show that the estimator of partial measures is asymptotically mutually independent for a large sample size. The present paper proposes a symmetry measure in the class of weighted averages that is different from previous studies. The proposed measure is an approximation of the measure in the class of weighted averages that has the smallest variance.
Open AccessPartial Asymmetry Measures for Square Contingency Tables
In square contingency table analysis, we consider a partial measure that represents the degree of departure from symmetry for each of several pairs. It may be useful to pool the values of the measure into a single summary measure of partial asymmetry. We show that the estimator of partial measures is asymptotically mutually independent for a large sample size. The present paper proposes a symmetry measure in the class of weighted averages that is different from previous studies. The proposed measure is an approximation of the measure in the class of weighted averages that has the smallest variance.
- Open Access
- 1 June 2021
- Published by Walter de Gruyter GmbH in Biometrical Letters
- Vol. 58 (1) , 81-94
Measure of departure from average marginal homogeneity for the analysis of collapsed ordinal square contingency tables
Summary: In clinical research, collected data are often classified into ordered categories using a set threshold to evaluate efficacy and safety of treatment. Data can be summarized as a shift table, which displays the change in the frequency of subjects across specified categories from the baseline to post-baseline. Although ordered categories are sometimes recombined into three categories, the combined patterns vary. To consider various collapsed patterns comprehensively, this paper proposes a new measure that represents the degree of departure from average marginal homogeneity, and can distinguish between two kinds of marginal inhomogeneity. Additionally, applications of the proposed measure to clinical data are discussed.
- 1 June 2021
- Published by Walter de Gruyter GmbH in Biometrical Letters
- Vol. 58 (1) , 81-94
Open AccessMeasure of departure from average marginal homogeneity for the analysis of collapsed ordinal square contingency tables
Summary: In clinical research, collected data are often classified into ordered categories using a set threshold to evaluate efficacy and safety of treatment. Data can be summarized as a shift table, which displays the change in the frequency of subjects across specified categories from the baseline to post-baseline. Although ordered categories are sometimes recombined into three categories, the combined patterns vary. To consider various collapsed patterns comprehensively, this paper proposes a new measure that represents the degree of departure from average marginal homogeneity, and can distinguish between two kinds of marginal inhomogeneity. Additionally, applications of the proposed measure to clinical data are discussed.
- Open Access
- 18 March 2021
- Published by MDPI AG in International Journal of Neonatal Screening
- Vol. 7 (1) , 17
Clinical and Genetic Characteristics of Patients with Mild Hyperphenylalaninemia Identified by Newborn Screening Program in Japan
Phenylketonuria (PKU) and hyperphenylalaninemia (HPA), both identified in newborn screening, are attributable to variants in PAH. Reportedly, the p.R53H(c.158G>A) variant is common in patients with HPA in East Asia. Here, we aimed to define the association between p.R53H and HPA phenotype, and study the long-term outcome of patients with HPA carrying p.R53H. We retrospectively reviewed the genotype in 370 patients detected by newborn screening, and identified the phenotype in 280 (117, HPA; 163, PKU). p.R413P(c.1238G>C) was the most frequently found (n = 117, 31.6%) variant, followed by p.R53H (n = 89, 24.1%). The odds ratio for heterozygous p.R53H to cause HPA was 48.3 (95% CI 19.410–120.004). Furthermore, we assessed the non-linear association between the phenylalanine (Phe) value and elapsed time using the follow-up data of the blood Phe levels of 73 patients with HPA carrying p.R53H. The predicted levels peaked at 161.9 μmol (95% CI 152.088–172.343) at 50–60 months of age and did not exceed 360 μmol/L during the 210-month long observation period. The findings suggest that patients with HPA, carrying p.R53H, do not need frequent Phe monitoring as against those with PKU. Our study provides convincing evidence to determine clinical management of patients detected through newborn screening in Japan.
- 18 March 2021
- Published by MDPI AG in International Journal of Neonatal Screening
- Vol. 7 (1) , 17
Open AccessClinical and Genetic Characteristics of Patients with Mild Hyperphenylalaninemia Identified by Newborn Screening Program in Japan
Phenylketonuria (PKU) and hyperphenylalaninemia (HPA), both identified in newborn screening, are attributable to variants in PAH. Reportedly, the p.R53H(c.158G>A) variant is common in patients with HPA in East Asia. Here, we aimed to define the association between p.R53H and HPA phenotype, and study the long-term outcome of patients with HPA carrying p.R53H. We retrospectively reviewed the genotype in 370 patients detected by newborn screening, and identified the phenotype in 280 (117, HPA; 163, PKU). p.R413P(c.1238G>C) was the most frequently found (n = 117, 31.6%) variant, followed by p.R53H (n = 89, 24.1%). The odds ratio for heterozygous p.R53H to cause HPA was 48.3 (95% CI 19.410–120.004). Furthermore, we assessed the non-linear association between the phenylalanine (Phe) value and elapsed time using the follow-up data of the blood Phe levels of 73 patients with HPA carrying p.R53H. The predicted levels peaked at 161.9 μmol (95% CI 152.088–172.343) at 50–60 months of age and did not exceed 360 μmol/L during the 210-month long observation period. The findings suggest that patients with HPA, carrying p.R53H, do not need frequent Phe monitoring as against those with PKU. Our study provides convincing evidence to determine clinical management of patients detected through newborn screening in Japan.
- Open Access
- 5 July 2019
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 19 (1) , 1-7
Thyroid blood flow in inferior thyroid artery as predictor for increase in levothyroxine dosage during pregnancy in women with Hashimoto's thyroiditis - a retrospective study
We examined whether inferior thyroid artery peak systolic velocity (ITA-PSV) predicts an increase in levothyroxine (LT4) dosage in pregnant women with Hashimoto’s thyroiditis. Twenty-two women with Hashimoto’s thyroiditis who were planning and later achieved pregnancy or confirmed as pregnant were enrolled in this retrospective longitudinal observational study. ITA-PSV and thyroid volume were measured using ultrasonography. Serum concentrations of free thyroxine (F-T4), free triiodothyronine (F-T3), and thyroid stimulating hormone (TSH) were simultaneously determined. We adjusted LT4 dosage to maintain serum TSH at < 2.5 μIU/mL (1st trimester) and later at < 3 μIU/mL (2nd, 3rd trimester). Eighteen patients (81.8%) required an increase in LT4 dosage during pregnancy, of whom 7 (31.8%) required an increase ≥50 μg. Multivariable regression analysis showed that TSH (β = 0.507, p = 0.008) and ITA-PSV (β = − 0.362, p = 0.047), but not thyroid volume, F-T4, or F-T3, were independently associated with increased LT4 dosage. Receiver-operating characteristic analysis for predicting an increase in LT4 ≥ 50 μg/day showed that the area under the curve (0.905) for ITA-PSV with TSH was not significantly increased (p = 0.123) as compared to that (0.743) for TSH alone, whereas integrated discrimination improvement was significantly increased (27.9%, p = 0.009). In pregnant patients with Hashimoto’s thyroiditis, ITA-PSV was a significant predictor of increase in LT4 dosage independent of TSH level, while ITA-PSV plus TSH showed significantly improved predictability as compared to TSH alone. These results suggest that ITA-PSV reflects residual thyroid function and is useful for evaluating the need for increased thyroid hormone production in pregnant patients with Hashimoto’s thyroiditis.
- 5 July 2019
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 19 (1) , 1-7
Open AccessThyroid blood flow in inferior thyroid artery as predictor for increase in levothyroxine dosage during pregnancy in women with Hashimoto's thyroiditis - a retrospective study
We examined whether inferior thyroid artery peak systolic velocity (ITA-PSV) predicts an increase in levothyroxine (LT4) dosage in pregnant women with Hashimoto’s thyroiditis. Twenty-two women with Hashimoto’s thyroiditis who were planning and later achieved pregnancy or confirmed as pregnant were enrolled in this retrospective longitudinal observational study. ITA-PSV and thyroid volume were measured using ultrasonography. Serum concentrations of free thyroxine (F-T4), free triiodothyronine (F-T3), and thyroid stimulating hormone (TSH) were simultaneously determined. We adjusted LT4 dosage to maintain serum TSH at < 2.5 μIU/mL (1st trimester) and later at < 3 μIU/mL (2nd, 3rd trimester). Eighteen patients (81.8%) required an increase in LT4 dosage during pregnancy, of whom 7 (31.8%) required an increase ≥50 μg. Multivariable regression analysis showed that TSH (β = 0.507, p = 0.008) and ITA-PSV (β = − 0.362, p = 0.047), but not thyroid volume, F-T4, or F-T3, were independently associated with increased LT4 dosage. Receiver-operating characteristic analysis for predicting an increase in LT4 ≥ 50 μg/day showed that the area under the curve (0.905) for ITA-PSV with TSH was not significantly increased (p = 0.123) as compared to that (0.743) for TSH alone, whereas integrated discrimination improvement was significantly increased (27.9%, p = 0.009). In pregnant patients with Hashimoto’s thyroiditis, ITA-PSV was a significant predictor of increase in LT4 dosage independent of TSH level, while ITA-PSV plus TSH showed significantly improved predictability as compared to TSH alone. These results suggest that ITA-PSV reflects residual thyroid function and is useful for evaluating the need for increased thyroid hormone production in pregnant patients with Hashimoto’s thyroiditis.